These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38299571)

  • 1. Monophasic coamorphous sulpiride: a leap in physicochemical attributes and dual inhibition of GlyT1 and P-glycoprotein, supported by experimental and computational insights.
    Pardhi E; Tomar DS; Khemchandani R; Bazaz MR; Dandekar MP; Samanthula G; Singh SB; Mehra NK
    J Biomol Struct Dyn; 2024 Feb; ():1-30. PubMed ID: 38299571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
    Yu D; Kan Z; Shan F; Zang J; Zhou J
    Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
    Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
    J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
    Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
    Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into the crystallization of coamorphous drug systems.
    Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
    J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.
    Fang X; Hu Y; Huang Z; Han L; Li B; Lu S; Cao Y
    J Pharm Sci; 2022 Jul; 111(7):2056-2071. PubMed ID: 35167885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization.
    M Tawfeek H; Hassan YA; Aldawsari MF; H Fayed M
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin.
    Wei Y; Zhou S; Hao T; Zhang J; Gao Y; Qian S
    Eur J Pharm Sci; 2019 Mar; 129():21-30. PubMed ID: 30590119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.
    Hatanaka Y; Uchiyama H; Kaneko S; Ueda K; Higashi K; Moribe K; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
    Mol Pharm; 2023 Aug; 20(8):4071-4085. PubMed ID: 37498232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
    Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
    AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of Molecular Interactions Between Drug-Polymer in Amorphous Solid Dispersion by a Computational Approach Using Molecular Dynamics Simulations.
    Aulifa DL; Al Shofwan AA; Megantara S; Fakih TM; Budiman A
    Adv Appl Bioinform Chem; 2024; 17():1-19. PubMed ID: 38282640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.
    Wang S; Heng W; Wang X; He X; Zhang Z; Wei Y; Zhang J; Gao Y; Qian S
    Int J Pharm; 2020 Oct; 588():119793. PubMed ID: 32827676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulpiride gastro-retentive floating microsponges; analytical study,
    Younis MA; El-Zahry MR; Tallat MA; Tawfeek HM
    J Drug Target; 2020 Apr; 28(4):386-397. PubMed ID: 31478760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution.
    Pisay M; Yarlagadda DL; Vullendula SKA; Bhat K; Kunnatur Balasundara K; Mutalik S
    Pharm Dev Technol; 2023 Feb; 28(2):176-189. PubMed ID: 36688412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
    Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
    Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
    Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
    J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Carrier Miscibility in Solid Dispersions of Glibenclamide and a Novel Approach to Enhance Its Solubility Using an Effervescent Agent.
    Pisay M; Bhaskar KV; Mehta CH; Nayak UY; Koteshwara KB; Mutalik S
    AAPS PharmSciTech; 2022 Oct; 23(8):284. PubMed ID: 36253571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocrystals of Apixaban with Improved Solubility and Permeability: Formulation, Physicochemical Characterization, Pharmacokinetic Evaluation, and Computational Studies.
    Madan JR; Waghmare SV; Patil RB; Awasthi R; Dua K
    Assay Drug Dev Technol; 2021; 19(2):124-138. PubMed ID: 33601935
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploration of interaction behavior between spiro[indene-2,2'-[1,3,5]oxathiazine]-1,3-diones and DNA with the help of DFT, molecular docking, and MD simulations.
    Salehpour M; Azizian J
    J Biomol Struct Dyn; 2022; 40(19):9194-9213. PubMed ID: 33998964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
    Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
    Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.